Florida’s Retirees Are Fleeing: Experts Predict These 5 States Will Be Top Retirement Spots in 10 Years ...

Greetings. Welcome to Mineralys third-quarter 2024 financial results conference call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce Dan ...

Mineralys Therapeutics, Inc. (MLYS – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today.

We recently completed enrollment in our pivotal Advance-HTN trial which is evaluating the efficacy and safety of lorundrostat ...

The 10-Q report also outlined the clinical highlights, including the ongoing clinical trials for lorundrostat, such as the ...

Men were more likely than women to have high blood pressure, federal officials found, but men were also less likely than women to know they had hypertension.

A 58-year-old male patient from Tripura was successfully treated for critical illnesses including septic shock and multi-organ dysfunction syndrome after 32 days at Father Muller Medical College ...

Hypertension is the most common cardiovascular disease (CVD) comorbidity seen among dialysis patients globally.

Researchers have found that, regardless of BP level and age, secondary hypertension is common among young adults with hypertension.

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) has announced that it has successfully completed enrollment in the launch-htn trial ahead of schedule. The trial is the second of two trials under the ...

Mineralys Therapeutics (MLYS) has completed enrollment in the Launch-HTN trial ahead of schedule. Launch-HTN is the second of two trials under ...

Chemistry and life science teams can instantly impact drug discovery and upskill work through Balto's data collection and modeling toolkit ...